United Asset Strategies’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,129	Closed	-$771K	–	246
2024 Q1	$771K	Buy	+8,129	New	+$754K	0.08%	168
2023 Q4	–	Sell	-2,796	Closed	-$204K	–	254
2023 Q3	$204K	Buy	+2,796	New	+$223K	0.03%	219
2022 Q1	–	Sell	-3,409	Closed	-$382K	–	241
2021 Q4	$382K	Sell	3,409 -3,198	-48%	-$386K	0.05%	168
2021 Q3	$831K	Buy	6,607 +440	+7%	+$56.7K	0.11%	128
2021 Q2	$835K	Sell	6,167 -230	-4%	-$30.2K	0.11%	126
2021 Q1	$868K	Sell	6,397 -2,347	-27%	-$351K	0.13%	117
2020 Q4	$1.23M	Buy	8,744 +1,056	+14%	+$135K	0.19%	92
2020 Q3	$857K	Sell	7,688 -1,690	-18%	-$189K	0.16%	102
2020 Q2	$1.05M	Sell	9,378 -165	-2%	-$16.3K	0.21%	90
2020 Q1	$739K	Sell	9,543 -2,205	-19%	-$195K	0.18%	100
2019 Q4	$1.12M	Buy	11,748 +960	+9%	+$83K	0.22%	98
2019 Q3	$823K	Buy	10,788 +315	+3%	+$26.2K	0.18%	104
2019 Q2	$919K	Sell	10,473 -165	-2%	-$14.1K	0.21%	100
2019 Q1	$963K	Sell	10,638 -70	-0.7%	-$5.96K	0.23%	101
2018 Q4	$768K	Sell	10,708 -425	-4%	-$34.2K	0.21%	101
2018 Q3	$1.07M	Sell	11,133 -144	-1%	-$14K	0.25%	94
2018 Q2	$1.07M	Sell	11,277 -420	-4%	-$38.6K	0.28%	89
2018 Q1	$1.03M	Sell	11,697 -1,534	-12%	-$140K	0.3%	86
2017 Q4	$1.12M	Buy	+13,231	New	+$1.11M	0.3%	81
2017 Q3	–	Sell	-18,561	Closed	-$1.43M	–	172
2017 Q2	$1.43M	Sell	18,561 -43,810	-70%	-$3.11M	0.43%	64
2017 Q1	$4.33M	Buy	+62,371	New	+$4.19M	1.32%	29